Literature DB >> 27380559

The role of the tissue factor pathway in haemostasis and beyond.

John H McVey1.   

Abstract

PURPOSE OF REVIEW: The role of tissue factor (TF) in the initiation of the blood coagulation network leading to generation of a fibrin clot has been well defined over the past 50 years. Although much is known about this sequence of events and its regulation, many important questions remain unresolved. More recently, a complex role for TF in cellular processes independent of fibrin generation has emerged. This review summarizes some of the advances in this field. RECENT
FINDINGS: TF is the cellular receptor and cofactor for factor VII/VIIa; however, controversy still surrounds expression of TF within the vasculature, the role of circulating microvesicle pools of TF and mechanisms of 'encryption' of TF activity. However, there have been significant advances in the role of TF-initiated cell signalling. Lastly, an alternatively spliced TF transcript has been identified and some insights into its role in cancer cell metastasis/proliferation have been elucidated.
SUMMARY: Understanding of TF structure function has increased substantially; however, multiple controversies still surround some aspects of its regulation. TF has emerged as a pivotal player in orchestrating not only fibrin generation but wound repair. Derangement of these repair processes contributes significantly to the pathophysiology of a number of disease processes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27380559     DOI: 10.1097/MOH.0000000000000268

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  8 in total

1.  Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome.

Authors:  Bruna de Moraes Mazetto; Mariana Lazarini; Lais Quinteiro Tobaldini; Fernanda Talge Arantes; Ana Paula Rosa Dos Santos; Bruna Cardoso Jacinto; Camila de Oliveira Vaz; Gabriela Tripiquia Vechiatto Mesquita; Sabrina da Silva Saraiva; Joyce Annichino-Bizzacchi; Fernanda Andrade Orsi
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

Review 2.  Single-chain factor XII: a new form of activated factor XII.

Authors:  Ivan Ivanov; Anton Matafonov; David Gailani
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

Review 3.  Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia.

Authors:  Pratima Chowdary
Journal:  Int J Hematol       Date:  2018-10-09       Impact factor: 2.490

4.  Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities.

Authors:  Mohammad A Mohammad; John Greenman; Anthony Maraveyas; Camille Ettelaie
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

Review 5.  Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.

Authors:  Francesco Bernardi; Guglielmo Mariani
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

Review 6.  Extracellular vesicles as regulators of kidney function and disease.

Authors:  Felix Behrens; Johannes Holle; Wolfgang M Kuebler; Szandor Simmons
Journal:  Intensive Care Med Exp       Date:  2020-12-18

Review 7.  Proteolytic activity of contact factor zymogens.

Authors:  Aleksandr Shamanaev; Jonas Emsley; David Gailani
Journal:  J Thromb Haemost       Date:  2020-12-07       Impact factor: 5.824

8.  Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.

Authors:  Louise Tzung-Harn Hsieh; Scott J Dos Santos; Belinda S Hall; Joy Ogbechi; Aloysius D Loglo; Francisco Javier Salguero; Marie-Thérèse Ruf; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.